The number of pages within the document is: 45
The self-declared author(s) is/are:
SYSTEM
The subject is as follows:
Original authors did not specify.
The original URL is: LINK
The access date was:
2019-02-07 23:00:24.024863
Please be aware that this may be under copyright restrictions. Please send an email to admin@pharmacoengineering.com for any AI-generated issues.
Loading...
Reload document 
Open in new tab The content is as follows:
European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use 7 Westferry Circus, Canar y Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 70 40 E-mail: mail@emea.europa.eu www.emea.europa.eu EMEA 2006 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged London, 28 July 2006 EMEA/CHMP/PEG/194810/2005 COMMITTEE FOR MEDICINAL PR ODUCTS FOR HUMAN USE (CHMP) REFLECTION PAPER: FORMULATIONS OF CHOICE FOR THE PAEDIATRIC POPULATION AGREED BY PAEDIATRIC WORKING PARTY & QUALITY WORKING PARTY May 2005 ADOPTION BY CHMP FOR RELEASE FOR CONSULTATION 23 June 2005 END OF CONSULTATION (DEADLINE FOR COMMENTS) 31 December 2005 AGREED BY PAEDIATRIC WORKING PARTY 28 July 2006 ADOPTION BY CHMP 21 September 2006
Please note all content on this page was automatically generated via our AI-based algorithm. Please let us know if you find any errors.